Notebook

MORE WORK NEEDED: Scientists have discovered a Parkinson's disease gene, but aren’t certain how many cases are caused by its mutation. The end of June brought with it a pair of studies with potentially valuable information on neurological disorders. In one (M. Polymeropoulos et al., Science, 276:2045-7, 1997), researchers from the National Human Genome Research Institute (NHGRI) and from Robert Wood Johnson Medical School in Piscataway, N.J., reported the first-ever discovery of a gene w

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

MORE WORK NEEDED: Scientists have discovered a Parkinson's disease gene, but aren’t certain how many cases are caused by its mutation. The end of June brought with it a pair of studies with potentially valuable information on neurological disorders. In one (M. Polymeropoulos et al., Science, 276:2045-7, 1997), researchers from the National Human Genome Research Institute (NHGRI) and from Robert Wood Johnson Medical School in Piscataway, N.J., reported the first-ever discovery of a gene whose mutation can lead to Parkinson's disease. The gene plays a role in the function of nerve cells by coding for a protein called alpha synuclein. The team speculates that the mutation causes an excess of alpha synuclein to gather in brain cells; this excess then attracts other proteins to form deposits that damage the cells. Senior author Robert Nussbaum, chief of NHGRI's Laboratory of Genetic Disease Research, says researchers don't yet know how many cases ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies